AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CUE ENERGY RESOURCES LIMITED

0.100

-0.005-4.76%

Volume:183.16K

Turnover:18.32K

Market Cap:69.98M

PE:16.13

High:0.100

Open:0.100

Low:0.100

Close:0.105

52wk High:0.151

52wk Low:0.096

Shares:699.78M

Float Shares:297.04M

Volume Ratio:1.28

T/O Rate:0.06%

Dividend:0.01

Dividend Rate:5.00%

EPS(TTM):0.006

EPS(LYR):0.006

ROE:7.57%

ROA:6.41%

PB:1.23

PE(LYR):16.13

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Central Petroleum Drills Northern Territory Gas Well With Commissioning Expected in October

MT Newswires Live

Cue Energy Resources Ltd-Retirement of Non-Executive Director

THOMSON REUTERS

Top Midday Decliners

MT Newswires Live

Cue Biopharma Meets Primary Goal in a Phase 2 Study of Chronic Hives Disease Drug Candidate

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/CUE.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CUE.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CUE.AU\",,,,,undefined,":{"symbol":"CUE.AU","market":"AU","secType":"STK","nameCN":"CUE ENERGY RESOURCES LIMITED","latestPrice":0.1,"timestamp":1791436320000,"preClose":0.105,"halted":0,"volume":183159,"delay":0,"changeRate":-0.04761904761904753,"nameEN":"CUE ENERGY RESOURCES LIMITED","floatShares":297038373,"shares":699779286,"eps":0.006199,"marketStatus":"Not Yet Opened","change":-0.005,"latestTime":"10-08 16:12:00 AEDT","open":0.1,"high":0.1,"low":0.1,"amount":18316,"amplitude":0,"askPrice":0.11,"askSize":99000,"bidPrice":0.1,"bidSize":20271,"shortable":3,"etf":0,"ttmEps":0.006199,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791500400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.105,"dividendRate":0.05,"openAndCloseTimeList":[[1791414000000,1791435600000]],"volumeRatio":1.281113475266597,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CUE.AU","preClose":0.105,"auctionPrice":0.105,"auctionVolume":137,"auction":3,"marketStatus":"盘后竞价","timestamp":1791262801028}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CUE.AU\",,,,,undefined,":{"symbol":"CUE.AU","floatShares":297038373,"roa":"6.41%","roe":"7.57%","lyrEps":0.006199,"volumeRatio":1.281113475266597,"shares":699779286,"dividePrice":0.005,"high":0.1,"amplitude":0,"preClose":0.105,"low":0.1,"week52Low":0.096,"pbRate":"1.23","psRate":"1.39","week52High":0.151,"institutionHeld":0,"latestPrice":0.1,"committee":-0.660085,"eps":0.006199,"divideRate":0.05,"volume":183159,"delay":0,"ttmEps":0.006199,"open":0.1,"prevYearClose":0.11,"prevWeekClose":0.105,"prevMonthClose":0.107,"prevQuarterClose":0.107,"fiveDayClose":0.11,"twentyDayClose":0.112,"sixtyDayClose":0.103,"dividendPayoutRate":1.205012853470437,"dividendFrequency":"A","dividendGrowthYears":0,"dividendGrowthRate":-0.625,"fiveYearAvgDividendRate":0.1668666703030964},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CUE.AU\",params:#limit:5,,,undefined,":[{"date":"2026-10-01","symbol":"CUE.AU","amount":0.0025,"announcedDate":"2026-08-27","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-10-02","defaultRemindTime":1790812800000,"name":"CUE ENERGY RESOURCES LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-15","payableDate":"2026-10-02","currency":"AUD","dateTimestamp":1790776800000,"payDate":"2026-10-15"},{"date":"2026-03-11","symbol":"CUE.AU","amount":0.0025,"announcedDate":"2026-02-25","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-12","name":"CUE ENERGY RESOURCES LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-26","payableDate":"2026-03-12","currency":"AUD","dateTimestamp":1773147600000,"payDate":"2026-03-26"},{"date":"2025-09-10","symbol":"CUE.AU","amount":0.005,"announcedDate":"2025-08-22","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-11","defaultRemindTime":1757462400000,"name":"CUE ENERGY RESOURCES LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-25","payableDate":"2025-09-11","currency":"AUD","dateTimestamp":1757426400000,"payDate":"2025-09-25"},{"date":"2025-03-11","symbol":"CUE.AU","amount":0.01,"announcedDate":"2025-02-25","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-03-12","name":"CUE ENERGY RESOURCES LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-12","currency":"AUD","dateTimestamp":1741611600000,"payDate":"2025-03-26"},{"date":"2024-09-11","symbol":"CUE.AU","amount":0.01,"announcedDate":"2024-08-23","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-09-12","defaultRemindTime":1726012800000,"name":"CUE ENERGY RESOURCES LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-26","payableDate":"2024-09-12","currency":"AUD","dateTimestamp":1725976800000,"payDate":"2024-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CUE.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2024-03-21","recordDate":"2024-03-22","paymentDate":"2024-04-05","value":0.02,"currency":"AUD"},{"executeDate":"2024-09-11","recordDate":"2024-09-12","paymentDate":"2024-09-26","value":0.01,"currency":"AUD"},{"executeDate":"2025-03-11","recordDate":"2025-03-12","paymentDate":"2025-03-26","value":0.01,"currency":"AUD"},{"executeDate":"2025-09-10","recordDate":"2025-09-11","paymentDate":"2025-09-25","value":0.005,"currency":"AUD"},{"executeDate":"2026-03-11","recordDate":"2026-03-12","paymentDate":"2026-03-26","value":0.0025,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CUE.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673500023","title":"Central Petroleum Drills Northern Territory Gas Well With Commissioning Expected in October","url":"https://stock-news.laohu8.com/highlight/detail?id=2673500023","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673500023?lang=en_us&edition=fundamental","pubTime":"2026-10-08 13:46","pubTimestamp":1791438389,"startTime":"0","endTime":"0","summary":"Central Petroleum  drilled the PV14 well in the Northern Territory to a total measured depth of 2,942 meters, equivalent to a true vertical depth of 2,096 meters, according to a Thursday filing with the Australian bourse.The well is expected to be tied into the Palm Valley production facility and commissioned by the end of October, per the filing.The well was tested for 90 minutes and reached a final estimated gas rate of about 3.2 terajoules per day, with no water or oil recovered. However, the company said the gas rate did not stabilize after 90 minutes and was still \"increasing slowly\" following the short-duration flow test.PV14 is part of a joint venture between Central Petroleum with a 50% stake, Echelon Resources  with a 35% interest, and Cue Energy Resources  holding the remaining 15%.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CUE.AU","ECH.AU","BK7142","CTP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672583733","title":"Cue Energy Resources Ltd-Retirement of Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2672583733","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672583733?lang=en_us&edition=fundamental","pubTime":"2026-10-01 07:47","pubTimestamp":1790812078,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nTUE4GXWML:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7142","CUE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669160698","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2669160698","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669160698?lang=en_us&edition=fundamental","pubTime":"2026-09-22 02:28","pubTimestamp":1790015325,"startTime":"0","endTime":"0","summary":"Cue Biopharma  shares slumped nearly 31% even after the company said a phase 2 trial of CUE-221 met its primary endpoint in certain patients with moderate-to-severe chronic spontaneous urticaria in China.Almost 2.67 million shares of the company traded intraday, compared with a daily average of about 170,000.Lument Finance Trust's  board suspended its quarterly dividend that would have otherwise been paid in October, it said late Friday.Shares dropped more than 12% as intraday trading volume climbed to almost 79,000 from a daily average of over 28,000.BofA Securities adjusted the share price target for United Parcel Service  to $108 from $115 while maintaining a neutral rating.Shares traded 4.3% lower intraday, with trading volume at nearly 5.83 million from a daily average of about 4.72 million.Price: 25.82, Change: -11.23, Percent Change: -30.31","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFSS8Q28.SGD","IYT","HULL","LU0070302665.USD","LU1162221912.USD","IE00B7KXQ091.USD","LU0320765646.SGD","IE00BJJMRX11.SGD","IE00BJJMRY28.SGD","LFT","LU0208291251.USD","LU1430594728.SGD","IE00B19Z3581.USD","LU2237438978.USD","IE0004445015.USD","LU0211326839.USD","LU0052756011.USD","LU0061475181.USD","LU1894683264.USD","BK4585","LU1585245621.USD","BK4559","BK4588","UPS","IE00BFSS7M15.SGD","CUE.AU","LU0128525689.USD","LU0149725797.USD","BK7095","DOCK","LU2133065610.SGD","LFT.AU","LU0320765489.SGD","BK4534","LU0976567544.SGD","BK4131","SHPP","UPSG","LU1894683348.USD","LU0211326755.USD","BK4139","BK4110","SUPL","BK7142","IE00B19Z3B42.SGD","LU1074936037.SGD","CUE","LU0211331839.USD","IE0002270589.USD","LU1267930227.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669153432","title":"Cue Biopharma Meets Primary Goal in a Phase 2 Study of Chronic Hives Disease Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2669153432","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669153432?lang=en_us&edition=fundamental","pubTime":"2026-09-21 15:26","pubTimestamp":1789975580,"startTime":"0","endTime":"0","summary":"Cue Biopharma  said Sunday a phase 2 trial of its CUE-221 in China met its primary endpoint in certain patients with moderate-to-severe chronic spontaneous urticaria, a skin condition.The primary endpoint, the percentage of patients with no hives at week 12, was met at all dose levels in a dose-responsive manner, the company said. It also said that the highest dose met the key secondary endpoint of complete resolution of hives at week 12.The benefit was also maintained for up to 12 weeks after treatment ended, with the response peaking at week 22, the company said.Cue Biopharma enrolled 145 patients in the study and tested three doses of the drug candidate over 16 weeks, followed by a 20-week follow-up.Cue said it plans to rapidly begin a phase 2/3 study in and continue development of CUE-221 in food allergy.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CUE","BK7142","BK4139","CUE.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":11,"pageCount":1,"totalSize":42,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CUE.AU\",params:#limit:6,delay:true,,,undefined,":[]}}